Chemogenetically activatable palmitoylation-regulating fusion proteins of the present invention can irreversibly regulate the palmitoylation of target proteins present in cell membranes through compound treatment, thereby exhibiting excellent diagnostic, preventive, and therapeutic effects for diseases associated with palmitoylation.
